Dr. Tricia Cottrell is an immunologist and pathologist whose research focuses on advancing clinical biomarker tests through studying tumour tissue specimens from patients enrolled in clinical trials. She completed her training (MD, PhD, anatomic pathology residency, and post-doctoral research fellowship) at Johns Hopkins School of Medicine in Baltimore, MD. As a post-doctoral fellow, Dr. Cottrell was involved in one of the first neoadjuvant clinical trials of anti-PD-1 therapy and was the first to characterize immune-related pathologic response following checkpoint blockade. Dr. Cottrell joined the CCTG in 2019 and her role focuses on neoadjuvant immunotherapy clinical trials, trial associated correlative science, and the National Tumour Tissue Repository at CCTG. She is also an Assistant Professor in the Department of Pathology and Molecular Medicine and runs a research lab in the Division of Cancer Biology and Genetics in the Queen’s Cancer Research Institute.
Areas of expertise: Clinical trials, thoracic and genitourinary cancers, neoadjuvant immunotherapy, pathologic response, tumour immune microenvironment
Research interests: Dr. Cottrell’s research lab focuses on mapping complex interactions between cancer cells and the immune system using multiplex immunofluorescence and digital image analysis, focusing on thoracic malignancies. https://www.cottrelllab.org/
Complete list of publications